Replimune Group’s REPL share price is down 63% in the pre-market hours today after the company announced that the FDA has issued a second complete response letter (CRL) against its resubmitted ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Pushed to the brink of extinction by a pandemic, humanity’s last hope lies in a deep-sea facility. But when a werewolf infiltrates the crew, the brilliant scientists are thrust into a deadly game of ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ:REPL) between ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / WHY: New York, N.Y., August 24, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ:REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the "Class ...